SE (NASDAQ:ARGX) said on Friday that it has received approval from the European Commission for its IgG Fc-antibody fragment, ...

Other common causes can also affect insulin effectiveness.

Managing type 2 diabetes usually requires medication to control blood sugar, and in some cases, patients must take insulin injections every day. But what if there was a way to treat diabetes ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Thus, inhaled insulin may provide an alternative to subcutaneous insulin in the management ... unwilling or unable to use preprandial insulin injections. A preliminary report of this study was ...

Abstract: Patients affected by type 1 diabetes (T1D) suffer from lack of insulin secretion by the pancreas, due to the autoimmune destruction of the insulinproducing beta cells. This translates into ...

Objective To determine if continuous subcutaneous insulin infusion (CSII) therapy is associated with lower glycated haemoglobin (HbA1c) variability (long-term glycaemic variability; GV) relative to ...

With an increasing number of subcutaneous drugs available in cancer treatment, oncology nurses are spending more time administering these injections, which can lead to exhaustion and soreness.

Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States ...

MONTREAL, May 27, 2025 /CNW/ - – Bristol Myers Squibb Canada (BMS) today announced that Health Canada has approved OPDIVO ® SC (nivolumab for subcutaneous injection) across all currently ...

Upon resuming subcutaneous insulin, a switch was made to long-acting ... to rule out lipodystrophies or other dermatological conditions, and multiple insulin injection sites were examined (arms, ...